Related Experiment Videos
Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate
J S Duncan1, S D Shorvon, M R Trimble
1Institute of Neurology, National Hospital, London, UK.
Journal of Neurology, Neurosurgery, and Psychiatry
|July 1, 1988
Abstract:
A prospective, double-blind, placebo-controlled investigation of possible withdrawal symptoms from phenytoin, carbamazepine and sodium valproate is reported in patients with active epilepsy, on combination therapy. There was an increase in seizures on reduction and withdrawal of carbamazepine, but there was no convincing evidence of withdrawal symptoms from any of these drugs.